← Leaderboards
Jacques Eduardo Nor
University Of Michigan At Ann Arbor
$18,171,241
Attributed
$18,171,241
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,171,241 · 10
By mechanism
R01$15,054,728 · 6
P50$1,893,647 · 1
R37$780,000 · 1
R21$418,866 · 1
U13$24,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Stephen Weiss$24,277,384
- Ormond A Macdougald$22,943,906
- Min Oh$170,523
- Marina Pasca Di Magliano$14,782,555
- Yvonne L Kapila$10,470,168
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionCellsIn VitroBasePathway InteractionsTumorTumor GrowthIn VivoEndothelial CellsCell LineNeoplastic CellVascular Endothelial Growth FactorsMalignant NeoplasmsMediatingBlood VesselsChemotherapyPharmaceutical PreparationsResearch StudyResistanceDesignTherapeutic EffectGrowthApoptosisScid Mice
Grant awards (55)
Regulation of dental pulp stem cell fate$390,000
R37 · FY2025 · DE · contact PI
Salivary gland cancer stem cells$370,500
R01 · FY2025 · DE · contact PI
Regulation of dental pulp stem cell fate$390,000
R37 · FY2024 · DE · contact PI
Salivary gland cancer stem cells$363,090
R01 · FY2024 · DE · contact PI
Salivary gland cancer stem cells$370,500
R01 · FY2023 · DE · contact PI
Salivary gland cancer stem cells$370,500
R01 · FY2022 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$370,500
R01 · FY2021 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$368,125
R01 · FY2021 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$370,500
R01 · FY2020 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$368,125
R01 · FY2020 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$401,656
R01 · FY2019 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$370,500
R01 · FY2019 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$441,428
R01 · FY2018 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$370,500
R01 · FY2018 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$39,556
R01 · FY2018 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$368,125
R01 · FY2017 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$368,125
R01 · FY2017 · DE · contact PI
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car$388,750
R01 · FY2015 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$388,750
R01 · FY2015 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$388,750
R01 · FY2014 · DE · contact PI
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car$388,750
R01 · FY2014 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$349,875
R01 · FY2014 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$560,104
P50 · FY2013 · CA · contact PI
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car$373,200
R01 · FY2013 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$373,200
R01 · FY2013 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$335,880
R01 · FY2013 · DE · contact PI
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car$388,750
R01 · FY2012 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$388,750
R01 · FY2012 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$349,875
R01 · FY2012 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$280,955
P50 · FY2012 · CA · contact PI
First Symposium on Head and Neck Cancer Stem Cells$4,000
U13 · FY2012 · DE · contact PI
Perivascular niche for salivary gland cancer stem cells and resistance to therapy$387,708
R01 · FY2011 · DE · contact PI
Mechanisms of dental pulp stem cell differentiation into functional endothelium$349,875
R01 · FY2011 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$266,140
P50 · FY2011 · CA · contact PI
First Symposium on Head and Neck Cancer Stem Cells$20,000
U13 · FY2011 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$301,955
P50 · FY2010 · CA · contact PI
Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis$336,521
R01 · FY2009 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$302,795
P50 · FY2009 · CA · contact PI
Endothelial and head & neck cancer stem cell crosstalks and resistance to therapy$227,703
R21 · FY2009 · DE · contact PI
Bcl-2 and CXC Chemokines in Head /Neck Tumor Angiogenesis /Metastasis$358,690
R01 · FY2008 · DE · contact PI
Therapeutic Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis$336,787
R01 · FY2008 · DE · contact PI
Endothelial and head & neck cancer stem cell crosstalks and resistance to therapy$191,163
R21 · FY2008 · DE · contact PI
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy$181,698
P50 · FY2008 · CA · contact PI
Bcl-2 and CXC Chemokines in Head /Neck Tumor Angiogenesis /Metastasis$362,679
R01 · FY2007 · DE · contact PI
Therapeutic Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis$340,794
R01 · FY2007 · DE · contact PI
Bcl-2 and CXC Chemokines in Head and Neck Tumor Angioge*$373,511
R01 · FY2006 · DE · contact PI
Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis$351,783
R01 · FY2006 · DE · contact PI
Neovascular Regression for Oral Cancer Therapy$255,518
R01 · FY2006 · DE · contact PI
Bcl-2 and CXC Chemokines in Head and Neck Tumor Angioge*$382,500
R01 · FY2005 · DE
Inhibition of Bcl-2 and Head &Neck Tumor Angiogenesis$362,204
R01 · FY2005 · DE
Neovascular Regression for Oral Cancer Therapy$261,742
R01 · FY2005 · DE
Bcl-2 /CXC Chemokines in Head /Neck Tumor Angiogenesis$382,500
R01 · FY2004 · DE
Neovascular Regression for Oral Cancer Therapy$261,815
R01 · FY2004 · DE
Neovascular Regression for Oral Cancer Therapy$261,886
R01 · FY2003 · DE
Neovascular Regression for Oral Cancer Therapy$261,955
R01 · FY2002 · DE